Volker Homuth

Title: The Innovations of Volker Homuth

Introduction

Volker Homuth is a notable inventor based in Munich, Germany. He has made significant contributions to the field of molecular medicine, particularly in the area of preeclampsia and malign hypertension. His work focuses on the development of peptides that can be used for diagnostic purposes.

Latest Patents

Homuth holds a patent that discloses peptides of the AT receptor. These peptides are designed for eliminating specifically binding, cell-physiologically active, pathological antibodies in preeclampsia and malign hypertension. The peptides may be utilized for the diagnosis of preeclampsia. Preferred sequences include AFHYESQ (SEQ ID NO: 1), AVHYQSN (SEQ ID NO: 2), SHFYQTR (SEQ ID NO: 3), GYYFDTN (SEQ ID NO: 4), and ENTNIT (SEQ ID NO: 5).

Career Highlights

Homuth is affiliated with the Max-Delbrück-Centrum für Molekulare Medizin, where he conducts his research. His work has been instrumental in advancing the understanding of molecular mechanisms related to hypertension and pregnancy-related conditions.

Collaborations

Some of his notable coworkers include Gerd Wallukat and Friedrich Luft. Their collaborative efforts have contributed to the success of various research projects in the field of molecular medicine.

Conclusion

Volker Homuth's innovative work in peptide development has the potential to significantly impact the diagnosis and treatment of preeclampsia and malign hypertension. His contributions to molecular medicine are noteworthy and continue to inspire further research in this critical area.